10/28/2013 PDA/FDA JOINT REGULATORY CONFERENCE: Great Place to Learn From Regulators
Bethesda, Md. – Many of the nearly 1,000 people who attended the 23rd Annual PDA/FDA Joint Regulatory Conference said the event provided them the opportunity to hear directly from regulators on the issues that affect them most, and from industry experts on how they are responding to these same issues.
8/19/2013 INTERPHEX and PDA Announce Agreement
NORWALK, CT, Aug. 19, 2013 – International Pharmaceutical Expo (INTERPHEX), the leading annual trade event dedicated to the pharmaceutical and biopharmaceutical industry and the Parenteral Drug Association (PDA) are pleased to announce a three-year Sponsorship Agreement.
2/1/2013 PDA Announces Establishment of New Chapter in Texas
“PDA has a long history of members in Texas and we are excited to introduce the PDA Texas Chapter. The area has a great mix of established pharma/bio industry, and is becoming a hub of new development, especially in new therapies.
12/14/2012 PDA Announces the Results of the 2013 Election
PDA is pleased to announce the results of the 2013 Board of Directors election. The elected candidates will fill their term beginning on January 1, 2013. Thank you to all who voted!
12/10/2012 PDA’s New Technical Report Portal is Now Open!
PDA Technical Reports are highly valued, global technical documents prepared by member-driven Task Forces comprised of content experts, including scientists and engineers working in the pharmaceutical and biopharmaceutical industry, regulatory authorities and academia.
9/21/2012 PDA’s Announces New Technical Report (TR) Portal by the End of 2012
“This is the most innovative and significant member benefit ever offered by The Parenteral Drug Association (PDA),” said Richard M. Johnson, PDA President. “We have been working hard on enhancing our member value and we believe that releasing this new Technical Report Portal by the end of 2012 is a breakthrough benefit that you just don’t see anywhere.
9/7/2012 PDA’s 2012 Universe of Pre-filled Syringes & Injection Devices - the Best Mindshare in the Industry
Our industry is entering a challenging phase for the next decade in the area of pre-filled syringes & injection devices. Costs and regulatory demands exert downward pressure on our ability to introduce devices that are safe and effective. Patients and their needs continue to grow while ever more complex molecules continue to challenge our material selection. Regulatory requirements, industry experience and evolving market trends are critical considerations to ensure a complete understanding of the application of pre-filled syringes and injection devices to drug delivery.